live attenuated varicella virus oka/merck strain

The vaccine is used for the prevention of varicella. It can be administered to individuals who have not previously had the disease. Additionally, vaccination within 3 days after contact with an infected person may prevent the development of the infection or mitigate its course.

Form: powder and solvent for injection suspension

ATC: J07BK01

Manufacturer: Merck Sharp & Dohme LLC, USA (Manufacturing, primary packaging and analytical testing of vaccine)